World

Pharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal

TARESH SINGH
0 Min Read

The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.

Share This Article
Previous Article Sanjay Dutt’s first look from ‘The Raja Saab’ out
Next Article How to properly water and care for your plants before leaving for a vacation
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Exit mobile version